Skip to content
Triangle logo TriangleGet started
← Full study record

NCT02593123 · MORE INFO

Limitations, agreements, and source contact

Adoptive Immunotherapy in Relapsed Hematological Malignancy: Early GVHD Prophylaxis · Source last updated 2023-01-23

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
true
point Of Contact
email
amir.toor@vcuhealth.org
organization
Virginia Commonwealth University Massey Cancer Center
phone
804 828 5116
title
Dr. Amir Toor, Principal Investigator
Complete source fields
certain Agreement
pi Sponsor Employee
true
point Of Contact
email
amir.toor@vcuhealth.org
organization
Virginia Commonwealth University Massey Cancer Center
phone
804 828 5116
title
Dr. Amir Toor, Principal Investigator

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice